British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.

doi:10.1136/ijgc-2020-002112

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Feb 2021

Sundar Sudha, Manchanda Ranjit, Gourley Charlie, George Angela, Wallace Andrew, Balega Janos, Williams Sarah, Wallis Yvonne, Edmondson Richard, Nicum Shibani, Frost Jonathan, Attygalle Ayoma, Fotopoulou Christina, Bowen Rebecca, Bell Dani, Gajjar Ketankumar, Ramsay Bruce, Wood Nicholas J, Ghaem-Maghami Sadaf, Miles Tracie, Ganesan Raji

Abstract excerpt

The British Gynecological Cancer Society and the British Association of Gynecological Pathologists established a multidisciplinary consensus group comprising experts in surgical gynecological oncology, medical oncology, genetics, and laboratory science, and clinical nurse specialists to identify the optimal pathways to BRCA germline and tumor testing in patients with ovarian cancer in routine clinical practice....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Carcinoma, Ovarian Epithelial

Share to Consensus

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Share to United Kingdom

Source

Open in PubMed

Identifiers

PMID: 33468564
DOI: 10.1136/ijgc-2020-002112

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.PMID 33468564Read ↗

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.Semantic proximity Read ↗

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.Semantic proximity Read ↗

AGO Austria recommendations for genetic testing of patients with ovarian cancer.Semantic proximity Read ↗

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionSemantic proximity Read ↗

UK BRCA mutation testing in patients with ovarian cancer.Semantic proximity Read ↗

Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.Semantic proximity Read ↗

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).Semantic proximity Read ↗

SEOM clinical guidelines in Hereditary Breast and ovarian cancer.Semantic proximity Read ↗

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.Semantic proximity Read ↗

<em>BRCA1/2</em> Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data StudySemantic proximity Read ↗

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.